Skip to content
Insurance Coverage of Prophylactic Mastectomies: A National Review of the United States.
Ha M, Ngaage LM, Finkelstein ER, Klein M, Yang A, Colohan SM, Nurudeen SM, Terhune JH, Slezak S, Rasko YM.
Clin Breast Cancer. 2022 Dec 5:S1526-8209(22)00269-5. doi: 10.1016/j.clbc.2022.12.001. Epub ahead of print.
Hereditary breast cancer: syndromes, tumour pathology and molecular testing.
Sokolova A, Johnstone KJ, McCart Reed AE, Simpson PT, Lakhani SR.
Histopathology. 2022 Dec 5. doi: 10.1111/his.14808. Epub ahead of print.
The CHK2 kinase is recurrently mutated and functionally impaired in the germline of pediatric cancer patients.
Wagener R, Walter C, Auer F, Alzoubi D, Hauer J, Fischer U, Varghese J, Dugas M, Borkhardt A, Brozou T.
Int J Cancer. 2022 Dec 5. doi: 10.1002/ijc.34390. Epub ahead of print.
Yes, We Can, But Should We? Ethical Considerations in Reporting Germline Findings From Paired Tumor-Normal Genomic Testing in Patients With Advanced Cancer.
Hunter CL, Helft PR.
J Clin Oncol. 2022 Dec 5:JCO2200796. doi: 10.1200/JCO.22.00796. Epub ahead of print.
Post navigation